Next Article in Journal
Fotemustine: A Third-Generation Nitrosourea for the Treatment of Recurrent Malignant Gliomas
Next Article in Special Issue
Tumor Microenvironment in the Brain
Previous Article in Journal
Diagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1)
Previous Article in Special Issue
Tertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer
Article

Tumor-Promoting Circuits That Regulate a Cancer-Related Chemokine Cluster: Dominance of Inflammatory Mediators Over Oncogenic Alterations

1
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
2
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel
*
Author to whom correspondence should be addressed.
Cancers 2012, 4(1), 55-76; https://doi.org/10.3390/cancers4010055
Received: 2 November 2011 / Revised: 13 January 2012 / Accepted: 17 January 2012 / Published: 20 January 2012
(This article belongs to the Special Issue Tumor Cell Genesis and Its Microenvironment: Chicken or the Egg)
Here, we investigated the relative contribution of genetic/signaling components versus microenvironmental factors to the malignancy phenotype. In this system, we took advantage of non-transformed fibroblasts that carried defined oncogenic modifications in Ras and/or p53. These cells were exposed to microenvironmental pressures, and the expression of a cancer-related chemokine cluster was used as readout for the malignancy potential (CCL2, CCL5, CXCL8, CXCL10). In cells kept in-culture, synergism between Ras hyper-activation and p53 dysfunction was required to up-regulate the expression of the chemokine cluster. The in vivo passage of RasHigh/p53Low-modified cells has led to tumor formation, accompanied by potentiation of chemokine release, implicating a powerful role for the tumor microenvironment in up-regulating the chemokine cluster. Indeed, we found that inflammatory mediators which are prevalent in tumor sites, such as TNFa and IL-1β, had a predominant impact on the release of the chemokines, which was substantially higher than that obtained by the oncogenic modifications alone, possibly acting through the transcription factors AP-1 and NF-kB. Together, our results propose that in the unbiased model system that we were using, inflammatory mediators of the tumor milieu have dominating roles over oncogenic modifications in dictating the expression of a pro-malignancy chemokine readout. View Full-Text
Keywords: Ras hyper-activation; p53 dysfunction; cluster of cancer-related chemokines; inflammatory cytokines; TNFα, IL-1β Ras hyper-activation; p53 dysfunction; cluster of cancer-related chemokines; inflammatory cytokines; TNFα, IL-1β
Show Figures

Figure 1

MDPI and ACS Style

Leibovich-Rivkin, T.; Buganim, Y.; Solomon, H.; Meshel, T.; Rotter, V.; Ben-Baruch, A. Tumor-Promoting Circuits That Regulate a Cancer-Related Chemokine Cluster: Dominance of Inflammatory Mediators Over Oncogenic Alterations. Cancers 2012, 4, 55-76. https://doi.org/10.3390/cancers4010055

AMA Style

Leibovich-Rivkin T, Buganim Y, Solomon H, Meshel T, Rotter V, Ben-Baruch A. Tumor-Promoting Circuits That Regulate a Cancer-Related Chemokine Cluster: Dominance of Inflammatory Mediators Over Oncogenic Alterations. Cancers. 2012; 4(1):55-76. https://doi.org/10.3390/cancers4010055

Chicago/Turabian Style

Leibovich-Rivkin, Tal, Yosef Buganim, Hilla Solomon, Tsipi Meshel, Varda Rotter, and Adit Ben-Baruch. 2012. "Tumor-Promoting Circuits That Regulate a Cancer-Related Chemokine Cluster: Dominance of Inflammatory Mediators Over Oncogenic Alterations" Cancers 4, no. 1: 55-76. https://doi.org/10.3390/cancers4010055

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop